Arm Faces Near-Term Risks as Morgan Stanley Turns Neutral
Morgan Stanley is neutral on Arm for now, raising its price target to $150 but warning growth may take time amid market risks.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Morgan Stanley is neutral on Arm for now, raising its price target to $150 but warning growth may take time amid market risks.
Broadcom teams up with Google to supply custom AI chips through 2031 and provide Anthropic 3.5 gigawatts of computing power.
Amazon will keep using USPS for most deliveries, sending over 1B packages yearly and supporting its finances and jobs.
AppLovin stock rises as Wells Fargo boosts target, citing strong ad growth, steady share, and confidence ahead of Q1 earnings.
FuboTV stock jumped on strong outlook. It may turn cash-positive by 2027 and grow fast, with enough cash to fund operations through 2028.
Lucid delivered fewer cars than expected due to a recall and supply issues, slowing sales and highlighting ongoing EV production challenges.